These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 19450571)
1. Panaxydol inhibits the proliferation and induces the differentiation of human hepatocarcinoma cell line HepG2. Guo L; Song L; Wang Z; Zhao W; Mao W; Yin M Chem Biol Interact; 2009 Sep; 181(1):138-43. PubMed ID: 19450571 [TBL] [Abstract][Full Text] [Related]
2. [Induction of differentiation by ginsenoside Rh2 in hepatocarcinoma cell SMMC-7721]. Zeng XL; Tu ZG Ai Zheng; 2004 Aug; 23(8):879-84. PubMed ID: 15301707 [TBL] [Abstract][Full Text] [Related]
3. Induction of apoptosis in rat C6 glioma cells by panaxydol. Hai J; Lin Q; Lu Y; Zhang H; Yi J Cell Biol Int; 2007 Jul; 31(7):711-5. PubMed ID: 17320424 [TBL] [Abstract][Full Text] [Related]
4. Induction of differentiation by panaxydol in human hepatocarcinoma SMMC-7721 cells via cAMP and MAP kinase dependent mechanism. Wang ZJ; Song L; Guo LC; Yin M; Sun YN Yakugaku Zasshi; 2011; 131(6):993-1000. PubMed ID: 21628989 [TBL] [Abstract][Full Text] [Related]
5. Growth inhibition and induction of differentiation by panaxydol in rat C6 glioma cells. Hai J; Lin Q; Lu Y; Yi J; Zhang H Neurol Res; 2008 Feb; 30(1):99-105. PubMed ID: 17767808 [TBL] [Abstract][Full Text] [Related]
6. Small-molecule c-Myc inhibitor, 10058-F4, inhibits proliferation, downregulates human telomerase reverse transcriptase and enhances chemosensitivity in human hepatocellular carcinoma cells. Lin CP; Liu JD; Chow JM; Liu CR; Liu HE Anticancer Drugs; 2007 Feb; 18(2):161-70. PubMed ID: 17159602 [TBL] [Abstract][Full Text] [Related]
7. IP6 in treatment of liver cancer. I. IP6 inhibits growth and reverses transformed phenotype in HepG2 human liver cancer cell line. Vucenik I; Tantivejkul K; Zhang ZS; Cole KE; Saied I; Shamsuddin AM Anticancer Res; 1998; 18(6A):4083-90. PubMed ID: 9891449 [TBL] [Abstract][Full Text] [Related]
8. Phosphatidylinositol 3-kinase activity is required for the induction of differentiation in C6 glioma cells by panaxydol. Hai J; Lin Q; Lu Y J Clin Neurosci; 2009 Mar; 16(3):444-8. PubMed ID: 19179079 [TBL] [Abstract][Full Text] [Related]
9. Effects of sodium phenylbutyrate on differentiation and induction of the P21WAF1/CIP1 anti-oncogene in human liver carcinoma cell lines. Meng M; Jiang JM; Liu H; In CY; Zhu JR Chin J Dig Dis; 2005; 6(4):189-92. PubMed ID: 16246228 [TBL] [Abstract][Full Text] [Related]
10. Cyclic AMP-dependent regulation of differentiation of rat C6 glioma cells by panaxydol. Hai J; Lin Q; Zhang H; Lu Y; Yi J Neurol Res; 2009 Apr; 31(3):274-9. PubMed ID: 19040798 [TBL] [Abstract][Full Text] [Related]
11. Overexpression of TIMP-1 mediated by recombinant adenovirus in hepatocellular carcinoma cells inhibits proliferation and invasion in vitro. Xia D; Yan LN; Xie JG; Tong Y; Yan ML; Wang XP; Zhang MM; Zhao LY Hepatobiliary Pancreat Dis Int; 2006 Aug; 5(3):409-15. PubMed ID: 16911941 [TBL] [Abstract][Full Text] [Related]
12. Panaxydol Derived from Panax ginseng Inhibits G Lee JH; Leem DG; Chung KS; Kim KT; Choi SY; Lee KT Biol Pharm Bull; 2018; 41(11):1701-1707. PubMed ID: 30381670 [TBL] [Abstract][Full Text] [Related]
13. Octreotide inhibits proliferation and induces apoptosis of hepatocellular carcinoma cells. Liu HL; Huo L; Wang L Acta Pharmacol Sin; 2004 Oct; 25(10):1380-6. PubMed ID: 15456543 [TBL] [Abstract][Full Text] [Related]
14. Bortezomib arrests the proliferation of hepatocellular carcinoma cells HepG2 and JHH6 by differentially affecting E2F1, p21 and p27 levels. Baiz D; Pozzato G; Dapas B; Farra R; Scaggiante B; Grassi M; Uxa L; Giansante C; Zennaro C; Guarnieri G; Grassi G Biochimie; 2009 Mar; 91(3):373-82. PubMed ID: 19041685 [TBL] [Abstract][Full Text] [Related]
15. Induction of apoptosis in human hepatocarcinoma SMMC-7721 cells in vitro by flavonoids from Astragalus complanatus. Hu YW; Liu CY; Du CM; Zhang J; Wu WQ; Gu ZL J Ethnopharmacol; 2009 Jun; 123(2):293-301. PubMed ID: 19429375 [TBL] [Abstract][Full Text] [Related]
16. [Reversing effect of dimethyl-4,4'-dimethoxy-5,6,5'6'-dimethylenedioxybiphenyl-2,2'- dicarboxylate(DDB) on the phenotypes of human hepatocarcinoma cell line]. Liu Z; Liu G; Zhang S Zhonghua Yi Xue Za Zhi; 1995 Nov; 75(11):676-8, 710. PubMed ID: 8697089 [TBL] [Abstract][Full Text] [Related]
17. Ascorbic acid induces redifferentiation and growth inhibition in human hepatoma cells by increasing endogenous hydrogen peroxide. Zheng QS; Zhang YT; Zheng RL Pharmazie; 2002 Nov; 57(11):753-7. PubMed ID: 12611279 [TBL] [Abstract][Full Text] [Related]
18. Antroquinonol displays anticancer potential against human hepatocellular carcinoma cells: a crucial role of AMPK and mTOR pathways. Chiang PC; Lin SC; Pan SL; Kuo CH; Tsai IL; Kuo MT; Wen WC; Chen P; Guh JH Biochem Pharmacol; 2010 Jan; 79(2):162-71. PubMed ID: 19723512 [TBL] [Abstract][Full Text] [Related]
19. Targeting alpha-fetoprotein represses the proliferation of hepatoma cells via regulation of the cell cycle. Tang H; Tang XY; Liu M; Li X Clin Chim Acta; 2008 Aug; 394(1-2):81-8. PubMed ID: 18485897 [TBL] [Abstract][Full Text] [Related]
20. Methanol extract of the seaweed Gloiopeltis furcata induces G2/M arrest and inhibits cyclooxygenase-2 activity in human hepatocarcinoma HepG2 cells. Bae SJ; Choi YH Phytother Res; 2007 Jan; 21(1):52-7. PubMed ID: 17078109 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]